Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)†

(2014) G. Folprecht et al.   ANNALS OF ONCOLOGY

Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival

(2014) Toru Beppu et al.   ANNALS OF SURGICAL ONCOLOGY

Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution

(2013) John B. Ammori et al.   ANNALS OF SURGICAL ONCOLOGY

Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis

(2013) Jun Ho Ji et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Liver resection for colorectal cancer metastases

(2013) S. Gallinger et al.   Current Oncology

Does “Conversion Chemotherapy” Really Improve Survival in Metastatic Colorectal Cancer Patients with Liver-Limited Disease?

(2013) K. Kataoka et al.   WORLD JOURNAL OF SURGERY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Curative Strategies for Liver Metastases from Colorectal Cancer: A Review

(2012) N. Zdenkowski et al.   ONCOLOGIST

The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review

(2012) Douglas Quan et al.   SURGERY

A Systematic Review of Clinical Response and Survival Outcomes of Downsizing Systemic Chemotherapy and Rescue Liver Surgery in Patients with Initially Unresectable Colorectal Liver Metastases

(2011) Vincent W. T. Lam et al.   ANNALS OF SURGICAL ONCOLOGY

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

(2011) Timothy S Maughan et al.   LANCET

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

(2009) Scott Kopetz et al.   JOURNAL OF CLINICAL ONCOLOGY